Sign up for LIFTED GLP-1 Blueprint today to get your discount code
Journal reference: Subodh Verma et al., Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure with Preserved Ejection Fraction, JACC 2024 , ISSN 0735-1097, DOI: 10.1016/j.jacc.2024.06.001
At 12 months, weight loss persisted at around 4%, with variability between agents, most notably liraglutide
doi: 10.1056/NEJMoa2032183, 73
Tirzepatide (Mounjaro, Zepbound) is a dual GIP and GLP-1 receptor agonist designed to reduce appetite and promote satiety, not increase hunger
This is further supported by several case reports (Table S3), which revealed solid gastric content via point-of-care ultrasound (POCUS), gastroscopy, or regurgitation despite proper fasting time according to current guidelines (Beam 2023